你即將離開本站

並前往https://www.nejm.org/doi/full/10.1056/nejmoa2024850

Idecabtagene Vicleucel in Relapsed and Refractory Multiple ...

In this phase 2 study, we sought to confirm the efficacy and safety of ide-cel in patients with relapsed and refractory myeloma.

確定！ 回上一頁

查詢 「nct study」的人也找了：

  1. Trials
    2.
  2. Clinical trial gov
    3.
  3. clinicaltrials.gov prs
    4.
  4. clinical trial gov登錄
    5.
  5. Clinical research
    6.
  6. clinical trial gov中文
    7.
  7. trial醫學
    8.
  8. Nct playlist
    9.